Related Experiment Video
Updated: May 17, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
A transcriptionally active pRb-E2F1-P/CAF signaling pathway is central to TGFβ-mediated apoptosis
1Division of Medical Oncology, Department of Medicine, McGill University Health Center, Montreal, Canada.
Abstract:
Transforming growth factor-β (TGFβ) modulates the expression of multiple apoptotic target genes; however, a common and central signaling pathway, acting downstream of TGFβ and leading to cell death, has yet to be uncovered. Here, we show that TGFβ-induced apoptosis in cancer cells requires the transcription factor E2F1 (E2 promoter-binding factor 1). Using the E2F1 knockout mouse model, we also found E2F1 to be required for TGFβ-mediated apoptosis in normal cells. Moreover, we found TGFβ to increase E2F1 protein stability, acting at the post-translational level. We further investigated the molecular mechanisms by which E2F1 contributes to TGFβ-mediated apoptosis and found that TGFβ treatment led to the formation of a transcriptionally active E2F1-pRb-P/CAF complex on multiple TGFβ pro-apoptotic target gene promoters, thereby activating their transcription. Together, our findings define a novel process of gene activation by the TGFβ-E2F1 signaling axis and highlight E2F1 as a central mediator of the TGFβ apoptotic program.
Insights
Transforming growth factor-β (TGFβ) induces apoptosis via the transcription factor E2F1. This study reveals TGFβ stabilizes E2F1 protein, leading to cell death in both cancer and normal cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor-β (TGFβ) is known to regulate apoptosis, but the central downstream signaling pathway remains unclear.
- Identifying key mediators of TGFβ-induced cell death is crucial for understanding cancer progression and developing therapeutic strategies.
Purpose of the Study:
- To elucidate the central signaling pathway downstream of TGFβ that mediates apoptosis.
- To identify the role of transcription factor E2F1 in TGFβ-induced cell death.
Main Methods:
- Utilized E2F1 knockout mouse models to assess TGFβ-mediated apoptosis in normal and cancer cells.
- Investigated the post-translational regulation of E2F1 by TGFβ.
- Analyzed the formation of E2F1-containing transcription complexes on target gene promoters.
Main Results:
- TGFβ-induced apoptosis requires the transcription factor E2F1 in both cancer and normal cells.
- TGFβ enhances E2F1 protein stability at the post-translational level.
- TGFβ promotes the formation of a transcriptionally active E2F1-pRb-P/CAF complex on pro-apoptotic gene promoters, activating their transcription.
Conclusions:
- E2F1 is a central mediator of the TGFβ apoptotic program.
- The TGFβ-E2F1 signaling axis represents a novel mechanism for gene activation leading to apoptosis.
Related Concept Videos
TGF - β Signaling Pathway
MAPK Signaling Cascades
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

